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Abstract
Context—The National Comprehensive Cancer Control Program (NCCCP) performance 
measurement system seeks to understand both the processes that funded programs undertake with 
their respective coalitions to implement the objectives of their cancer plans and outcomes of those 
efforts.
Objective—To identify areas of achievement and technical assistance needs of NCCCP 
awardees.
Design—Program performance was assessed through surveys completed by program directors on 
performance indicators in 2009 and 2010 and queries from a web-based management information 
system in 2011 and 2012.
Setting—Programs funded by CDC’s NCCCP.
Participants—69 programs.
Main Outcome Measure(s)—The key performance measures assessed were: inclusion of 
diverse partners and key sectors in cancer coalitions; partners’ involvement in activities; receiving 
in-kind resources from partners; using evidence-based interventions and data for setting priorities; 
conducting program evaluation; using community- or organization-level strategies to address 
cancer control efforts; and demonstrating progress toward achieving health outcomes.
Results—Most programs reported having active coalitions that represent diverse organizational 
sectors. Nearly all programs routinely assess the burden of cancer. In-kind resources to implement 
activities peaked at $64,716 in the second year of a five year funding cycle, and declined in 
subsequent project years. By year 3, over 70% of programs reported having an evaluation plan. 
While programs reported that nearly two-thirds of their interventions were evidence-based, some 
programs implemented non-evidence-based interventions. A majority of programs successfully 
used at least one community- or organization-level change strategy. However, many programs did 
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not incorporate objectives linked to health outcomes as they reported progress in implementing 
interventions. Conclusions: While NCCCP programs were strong at building and maintaining 
infrastructure, some programs may need additional technical assistance to increase the adoption of 
evidence-based interventions, develop solid and responsive evaluation plans, and better link 
efforts to population-based measures that demonstrate impact toward reducing the burden of 
cancer.
Keywords
cancer control; program evaluation/standards; program evaluation/utilization; performance 
measurement; public health administration; neoplasms/prevention and control; Public Health 
Practice/prevention and control
Introduction
Cancer remains a significant public health problem in the United States. In 2010, 
approximately 1.5 million incident cases were diagnosed,1 and over a half million people 
died from the disease, making it the second overall leading cause of death.2 While the 
overall age-adjusted incidence has been decreasing during the past decade, for some 
preventable cancer sites such as melanoma, incidence rates are increasing.3 As progress in 
cancer treatment advances, more Americans are surviving their cancer diagnosis,4 but they 
often face lower quality of life and other chronic health conditions.5,6
In 1998, the Centers for Disease Control and Prevention (CDC) piloted the National 
Comprehensive Cancer Control Program (NCCCP) with five state health departments and 
one tribal health board with existing state or tribal cancer control plans.7 Currently, CDC 
funds a total of 65 NCCCP awardees (states, territories, Pacific Island jurisdictions, and 
tribes/tribal organizations) in 69 comprehensive cancer control (CCC) programs to establish 
broad-based comprehensive cancer control (CCC) coalitions, assess the burden of cancer, 
and develop and implement CCC plans to reduce cancer incidence and mortality and 
improve the quality and duration of life among cancer survivors.8 CCC coalitions generally 
rely on volunteers from partner organizations on the premise that donated time and financial 
support can be leveraged from these stakeholders to plan and implement interventions from 
the CCC plan while integrating and coordinating activities that will more effectively address 
the cancer burden. Traditionally, CCC coalitions produce CCC plans that address the cancer 
control continuum (http://cancercontrol.cancer.gov/od/continuum.html), but they may 
prioritize plan implementation to a few key areas (e.g. tobacco control, colorectal cancer 
screening, etc.).
Increasingly, public health programs such as the NCCCP are expected to account for use of 
Federal funding by demonstrating measurable results-oriented outcomes.9 Performance 
measurement is one method of documenting accountability.10 Performance measurement 
systems are essential to program monitoring and quality improvement efforts and provide a 
platform to evaluate key programmatic efforts; thus findings should be actively used to 
improve programs.11-13 Often, these systems serve as the primary data source to directly 
evaluate programmatic efforts. Quality improvement activities and performance 
measurement are now commonplace in numerous health care settings.14 In public health, the 
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Government Performance and Results Act from the 1990’s, and more recently CDC’s 
National Public Health Performance Standards Program and the public health department 
accreditation movement reflect efforts to improve programmatic performance.9,15,16
In 2007, a set of performance measures was developed and pilot tested with 61 NCCCP 
awardees17 to measure performance in the five-year funding cycle spanning 2007-2012. To 
begin the process, data were systematically collected across all awardees to describe 
attributes of the NCCCP to invested stakeholders, document current progress, and foster 
quality improvement. The NCCCP performance measurement system is an integral part of 
ongoing NCCCP evaluation efforts that seek to understand both the processes that NCCCP 
awardees undertake with their respective CCC coalitions to develop and implement the 
objectives of their cancer plans and track the resulting health outcomes of those efforts so 
that quality may be continually improved. However, the primary objective of NCCCP 
evaluation efforts are to continually use evaluation findings to improve the program; 
therefore, we undertook an analysis of NCCCP performance measures data from 2008 – 
2012 (project years 2 – 5) to enhance our understanding of the current state of the NCCCP, 
recognize areas of achievement, and identify emerging issues that can be addressed through 
training and technical assistance as programs continue into a new funding period.
Methods
Data collection
As a condition of funding, NCCCP awardees are expected to report performance measures 
annually to CDC. Project year 2 represents the time period of June 30, 2008 through June 
29, 2009, while year 3 represents the time period of June 30, 2009 through June 29, 2010. 
The same convention follows for project years 4 – 5. Development and pilot testing of the 
NCCCP performance measurement system has been described previously.17 In 2008, the 
NCCCP performance measurement system was refined to clarify survey questions and 
strengthen indicators to more accurately measure activities and outcomes. Additional 
refinement of the survey occurred in 2009 and 2010 in response to program directors’ and 
program staff feedback and the need to collect data for emerging programmatic processes. 
Subsequently, some performance measures were removed and new ones were added. 
Therefore, data for some performance measures were not collected continuously throughout 
years 2 – 5.
In 2010, a web-based chronic disease management information system (CDMIS) was 
developed to collect programmatic data from select CDC chronic disease program awardees. 
The NCCCP was an inaugural member of CDMIS, and the NCCCP module systematically 
captures data from all NCCCP awardees about staff, CCC coalition members, resources 
(e.g., leveraged financial resources, donated meeting space, volunteer time, etc.), and 
planning tools (e.g. surveillance data sources and evaluation plans). Annual action plans that 
include objectives linked to overall five-year project period objectives, and describe 
programmatic work that form the basis for interim and annual progress reports are also 
included in CDMIS. In 2011, CDMIS replaced the previous NCCCP performance 
measurement system as the data collection tool, and was used solely for NCCCP 
performance measurement in project years 4 and 5. In order to reduce duplication of effort 
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and burden on awardees in reporting performance measures as well as to ensure continuity 
in measurement systems, key programmatic contextual information, action plans, progress 
reports, and performance reporting was seamlessly integrated throughout the data entry 
fields of the CDMIS NCCCP module. To facilitate reporting of performance measures and 
maintain transparency in the reporting process, a document was developed by CDC and 
disseminated to NCCCP awardees that mapped all existing NCCCP performance measures 
to data entry fields in CDMIS. Since only programmatic information was collected from 
respondents reporting performance measures, institutional review board approval was not 
required for data collection and analysis. Approval of data collection through CDMIS was 
obtained from the Office of Management and Budget (OMB Control #0920-0841). 
Response rates ranged from 98.6% of funded programs in years 2 – 3 to 100% in years 4 – 
5.
Performance measures that were assessed
NCCCP performance measures are indicators developed to address activities of the NCCCP 
that funded CCC programs conduct as a condition of funding that fall under the following 
domains: 1) Assess and enhance current infrastructure, 2) Build strong partnerships, 3) 
Assess the burden of cancer (i.e. incidence, mortality, and risk factors), 4) Mobilize support 
for comprehensive cancer control (e.g. receiving in kind resources from partners such as 
donated staff time, supplies, or meeting space), 5) Implement the cancer plan, 6) Conduct 
evaluation of the cancer plan 7) Use systems and environmental strategies to address the 
cancer burden, and 8) Monitor changes in population-based health outcomes. In this 
analysis, we focused on a subset of performance measures that represent key activities and 
measure impact of the NCCCP (see Table, Supplemental Digital Content 1 for the list of 
indicators and response options). The performance measures assessed were: 1) partners’ 
involvement in CCC activities; 2) inclusion of organizations that represent underserved/
underrepresented populations in cancer coalitions; 3) use of cancer surveillance data for 
setting priorities and program planning; 4) inclusion of key sectors in cancer coalitions; 5) 
ability to garner in-kind resources from partners; 6) inclusion of key aspects of the cancer 
care continuum in implementation activities with partners; 7) use of evidence-based 
interventions; 8) routine program evaluation; 9) use of environmental and systems change 
strategies to address cancer control; and 10) demonstration of progress toward achieving 
preset goals for cancer prevention and control.
Data Management and Analysis
Performance measurement data collected through the initial NCCCP performance 
measurement system (years 2 – 3) were entered into an MS Access database. Approximately 
one-third of records were reviewed for data entry errors and corrected, if necessary. All 
outliers were verified against the original data to identify and correct errors as needed. These 
data were imported into SAS version 9.2 (SAS Institute, Cary, NC) for analysis. For project 
years 4 and 5, we developed a set of CDMIS queries to systematically abstract data across 
all NCCCP awardees. Some data from years 4 and 5 were downloaded into MS Excel for 
additional analysis. Codebooks and a data analysis plan were developed so that analyses 
across years 4 and 5 were standardized. If assignment of categories was required to 
summarize data, assignment of predetermined codes would be consistent between years 
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based on inclusion and exclusion criteria. Sixty-eight NCCCP programs completed 
performance measurement in the initial NCCCP system in project years 2 and 3. In years 4 
-5, all NCCCP programs completed performance measurement and all used CDMIS for 
reporting (n=69). Because not all questions were asked every year, data not available for a 
given year are shown as “not applicable” (N/A). The most questions were asked in year 3 
because we developed new indicators to better measure some performance measures. 
However, many of the indicators new in year 3 were not included in CDMIS due to the 
system’s deployment schedule.
We calculated descriptive statistics using SAS version 9.2 for performance measures 
reported for years 2 and 3. For variables that were collected on a continuous scale (e.g. 
monetary amount of in-kind resources), we calculated the mean, median, range, and sum (if 
appropriate). The denominator in most analyses was the total number of NCCCP programs 
who reported performance measures in a given year. The numerator represented the number 
of programs meeting the indicator. However, in project year 2, one NCCCP program was 
still developing their cancer plan. Therefore, some analyses excluded this program. In some 
cases, programs were excluded from the denominator if they did not respond to the question 
or if the question did not apply to them (e.g. evaluation plan components if no evaluation 
plan was developed). For some analyses on the use of evidence-based interventions or 
proportion of partners implementing the cancer plan, we calculated a mean of the 
percentages that were reported by programs.
For project years 4 – 5, descriptive statistics were calculated using Excel based on results 
from the CDMIS queries.
Results
Table one presents findings from performance measures that assess infrastructure-related 
activities (partners’ involvement in CCC activities, inclusion of organizations that represent 
underserved/underrepresented populations in cancer coalitions, and use of cancer 
surveillance data for setting priorities and program planning; (performance measures 1-3). 
Seventy-nine percent of NCCCP programs conducted at least one in-person meeting with 
their entire CCC coalition in project year 3, and most reported that workgroups and the 
executive committee met at least 3 – 4 times during the course of the year (73.5% and 
82.4%, respectively). Most programs reported that partners volunteered to take the lead on 
action items (83.8%) and followed-up on action items in a timely manner (73.5%). In project 
year 2, NCCCP programs reported that an average of 60.4% of their partners implemented at 
least one priority strategy from the cancer plan. The majority of NCCCP programs with 
underserved/underrepresented populations residing in their jurisdictions reported having 
organizations that represent or serve these communities (range: 60.0% - 86.4%) on their 
coalitions. These results were highest for African-Americans, but lowest for Asians. In 
project years 4 and 5, 50.7% and 56.5% of NCCCP programs, respectively, reported having 
organizations that represent priority populations and cultural/ethnic organizations as key 
coalition partners.
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Nearly all NCCCP programs (92.3% in year 2 and 97.0% in year 3) routinely conducted a 
comprehensive review of their available cancer surveillance data (incidence, mortality, and 
prevalence of cancer screening and health behaviors linked to cancer), with a review 
conducted on average within the past two years in years 2 and 3 (1.3 and 1.2 years, 
respectively). In year 3, 57.4% of NCCCP programs shared results of a midpoint cancer 
surveillance data review during a partnership meeting, and 41.4% updated goals and 
objectives in their cancer plan based upon a review of data and trends. Slightly over half of 
programs in years 4 and 5 met their objectives for assessing the burden of cancer in their 
action plans reported to CDC through CDMIS (53.6% and 55.1%, respectively).
Most NCCCP programs reported having CCC coalitions that represent diverse 
organizational sectors (performance measure 4; Figure 1). Political leaders, business/
industry, and other government organizations tended to be reported less frequently, 
particularly in years 4 and 5. Most reported that they received in-kind resources (i.e. 
personnel/volunteers, meeting space, travel, etc.) for CCC efforts (performance measure 5); 
median values of these resources ranged from $40,005 (year 4) to $64,716 (year 2) across 
project years 2 – 5 (Figure 2).
Table 2 presents the results of performance measures that assess cancer plan implementation 
and outcomes of CCC activities (performance measures 6 - 8 and 10). Most programs 
reported addressing screening/early detection (range: 84.1% - 98.5%) and primary 
prevention of cancer (range: 79.7% - 92.6%) in their implementation activities. Fewer 
programs focused on diagnosis (range: 34.8% - 76.5%) and palliation/end-of-life care 
(range: 44.9% - 85.3%). On average, NCCCP programs reported that approximately two 
thirds of their implemented interventions were evidence-based (range: 60.4% - 67.5%), and 
over 85% had at least one action plan annual objective in CDMIS with an evidence-based or 
promising practice source identified (years 4 and 5). Most programs reported having or 
provided a copy of a formal evaluation plan (range: 50.7% - 70.6%), and the majority of 
programs with evaluation plans reported having addressed all NCCCP-required components 
of evaluation plans (range: 62.2% - 72.9%). Programs reported less often that they addressed 
potential effects of selected activities as an evaluation plan component (range: 68.9% - 
81.3%). While most NCCCP programs routinely monitor key population-based indicators 
for cancer control (year 3 range: 54.4% - 76.5%), few included these as project period 
objectives in their CDMIS action plans in years 4 – 5 .The most commonly reported 
population-based indicator was for colorectal cancer screening, which was reported by just 
over 40% of programs.
Fifty-two percent of NCCCP programs in year 4 and 63.8% in year 5 established and met at 
least one action plan annual objective that used an environmental or system change as a 
strategy (performance measure 9, Figure 3). Commonly addressed topic areas included 
tobacco, health disparities, access to care, breast or cervical cancer screening, colorectal 
cancer screening, and nutrition/physical activity/obesity.
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Discussion
Results from these performance measure indicators reveal that during the 2007-2012 project 
period, NCCCP programs were successful at developing diverse, active partnerships and 
routinely using cancer surveillance data to plan and implement cancer control interventions. 
However, throughout the funding cycle, not all programs consistently used evidenced-based 
interventions, conducted formal evaluations of program activities, or linked efforts to 
population-based measures that demonstrated impact toward reducing the burden of cancer. 
For example, even within core infrastructure indicators, some Tribal and Pacific Island 
jurisdiction programs reported that they did not have adequate cancer surveillance data for 
their populations (data not shown) to fully assess the cancer burden and monitor their 
programs. Additionally, while most programs reported using evidence-based or promising 
practice-based interventions, around half of programs had at least one action plan annual 
objective in CDMIS that cited “practice-based evidence: your own program” as part of the 
evidence source for implementing an intervention. In some cases this option was selected 
along with other evidence-based sources, possibly reflecting a desire on behalf of programs 
to acknowledge their own practice-based experiences in implementing evidence-based 
interventions that were adapted for use with their own populations. While most programs 
reported receiving in-kind resources, the total amount peaked in project year 2 and declined 
in subsequent project years, which may impact the ability to plan and implement activities. 
The majority of programs did not use population-based health indicators as action plan 
project period objectives, even though various data sources to monitor health outcomes are 
available to most programs.
The decreasing trend in in-kind resources reported by CCC programs may indicate that some 
programs had fewer staff and donated supplies available from partners and the CDC-funded 
health department to implement cancer control efforts. However, we did not collect the total 
amount of resources needed to implement the cancer plan to truly assess this finding. CCC 
programs are encouraged but not required to develop a resource plan, which may serve to 
promote the cancer plan, engage partners, articulate outcomes, and communicate the need 
for additional in-kind and leveraged resources.18
One challenge to a NCCCP performance measurement system is the issue of decentralized 
public health efforts and which entities are ultimately accountable for community health.10 
While public health departments may be held accountable for performance, in reality public 
health efforts are increasingly being implemented with partners.11,19 It may be challenging 
to collaborate with different partners that may not have any financial incentive for 
demonstrating performance and they often have their own set of priorities that may not 
always align with health department priorities.19-22 From the onset, collaboration and 
leveraging shared resources were embodied in the definition of CCC, making accountability 
and evaluation of NCCCP efforts challenging.
In 2012, the NCCCP ended a five-year project period, and a new five-year project period 
through 2017 began. Many of the same performance measures have been carried over into 
this new project period and included in the logic model, but there is now a greater emphasis 
on collaborating with partners by forming coalition workgroups to implement interventions 
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and coordinate activities with other chronic disease programs, including those that focus on 
primary prevention.18 NCCCP awardees are still encouraged to address the cancer burden 
through environmental and system change strategies.23 For example, programs include at 
least one project period objective in their action plan that addresses primary prevention of 
cancer and uses an environmental or system change strategy. CDC continues to emphasize 
using evidence-based interventions, and additional guidance and support are provided for 
interventions in NCCCP priority areas.
For a performance management system to be effective, use of performance measures must 
be tied to quality improvement efforts.11 Quality improvement in public health focuses on 
deliberate and defined improvement processes to achieve measurable improvements in the 
efficiency, effectiveness, performance, accountability, and outcomes of efforts.24 Public 
health services and systems research is a new field that developed out of a need to better 
understand how public health infrastructure affects population health outcomes.25,26 A key 
initiative of this movement is public health department accreditation, which emphasizes 
continuous quality improvement to ensure effective delivery of public health services.16,24 
Similar to NCCCP performance measures, domains of accreditation include the use of 
evidence-based practices and conducting evaluation. Emerging evidence suggests that local 
health departments who perform better at the core public health functions may have an 
increased impact on some community health outcomes.27
CDC continues to use performance measures to inform program design, better target 
technical assistance, drive public health translational research, provide needed insight into 
the NCCCP evaluation design, and guide NCCCP awardees to existing resources that may 
help them improve their programs. Results from performance measures have been 
incorporated into mid-year technical reviews of program progress, and detailed action plan 
reviews using a team approach that includes staff from a variety of disciplines (e.g. program 
delivery, epidemiology, evaluation, health services research). The aim of these reviews is to 
improve performance by gauging progress and helping to select appropriate evidence-based 
interventions that would promote efficient use of resources. As new funding opportunities 
are developed, results from performance measures will likely contribute to expectations for 
funded programs.
Understanding how CCC programs find and select evidence-based interventions is an 
ongoing area of study within the NCCCP.28 To aid NCCCP programs and their coalitions 
with evaluation efforts, a domain in which results from performance measures indicate an 
area that needs improvement, an evaluation toolkit and cancer plan index planning tool have 
been developed and disseminated.29 These tools were used by one NCCCP program to 
successfully conduct an outcome evaluation of their cancer plan,30 and their findings may be 
used to refine future cancer plan implementation efforts. Additionally, an external 
performance measures advisory workgroup consisting of CCC program directors working in 
state/tribal/Pacific Island jurisdiction health departments was convened to provide input into 
data interpretation and considerations for future refinement of measures. Webinars and 
conference calls that cover how CDC collects and uses performance measures continually 
inform CCC programs that performance measures are central to program monitoring and 
quality improvement efforts.
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Future research may assess if program performance among CCC programs is linked with 
desired health outcomes such as improved screening rates, reductions in cancer-related risk 
factors, and improvements in quality of life and health behaviors. Additionally, future 
research may focus on which composite of indicators is associated with making progress 
toward achieving health outcomes. Alternative study designs such as those used in systems 
design research along with statistical modeling may help address these questions.12 To 
achieve long-term cancer-related outcomes, sustaining high functioning coalitions should 
remain a priority, and CDC’s national partners are providing technical assistance workshops 
to coalitions to address this issue.31-33 Additionally, determining optimal benchmarks to set 
so that programs are in better position to achieve health outcomes may need attention. As 
the literature on coalition functioning evolves, it may be reasonable to align some 
performance measures with other indicators of coalition effectiveness.34
Strengths and limitations
This study has a number of strengths and limitations. A great strength is that the use of 
CDMIS increases the quantity of data that can be collected from NCCCP programs, 
providing a level of detail that can enhance our understanding of how NCCCP programs 
function. The use of CDMIS also helps to ensure that data are collected from awardees in a 
systematic fashion. Limitations include the fact that not all performance measure indicators 
were included in the CDMIS application, in order to meet the strict timelines of CDMIS 
deployment. Another limitation is that changing from a paper-based survey to seamless web-
based data entry may have introduced mode effects in the trend data, particularly for 
measures that are now queried from CDMIS action plans. Therefore, trend results need to be 
interpreted with caution. Third, performance measure data are self-reported by programs and 
results may be influenced by social desirability bias. Fourth, performance measure indicators 
provide a general overview of how well NCCCP programs are functioning, but their lack of 
depth may obscure other issues that may hinder programs’ progress in achieving health 
outcomes. For example, the quality of a particular intervention (as opposed to just its 
evidence-based nature) or evaluation plan may be obscured.
Conclusion
Results from the NCCCP performance measures indicate that most programs have the core 
infrastructure in place with their coalition partners to implement cancer control interventions 
and educate stakeholders on effective environmental or system change strategies for cancer 
control. In the future, technical assistance efforts may focus on improving the ability of 
programs to effectively use evidence-based interventions, improving the quality of CDMIS 
data, conducting continuous program quality improvement through evaluation, and 
conducting outcome evaluation to monitor the effects of cancer control efforts on 
population-based measures such as adolescent and adult tobacco use prevalence, obesity 
prevalence, and colorectal cancer screening. Performance measurement is a cornerstone of 
continuous quality improvement, and efforts to monitor performance remain a priority 
within the NCCCP.
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Figure 1. 
Percentage of National Comprehensive Cancer Control Programs having key sectors 
represented on their Comprehensive Cancer Control Partnership/Coalition, 2008 – 2012 
(Project Years 2 – 5)
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Figure 2. Median Value of In Kind Resources Reported by National Comprehensive Cancer 
Control Programs, 2008 – 2012 (Project Years 2 – 5)*
*Number of programs reporting in-kind resources by year: Year 2, n=61; Year 3, n=63; Year 
4, n=51; Year 5, n=61.
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Figure 3. Number of National Comprehensive Cancer Control Programs with Annual Objectives 
that use Environmental or Systems Change Strategies, Years 4a and 5b
aN=36 programs with met objectives (year 4);
bN=44 programs with met objectives (year 5)
cCross-cutting category
Abbreviations: HPV, human papillomavirus
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Table 1
Results of performance measures that assess infrastructure-related activities, National Comprehensive Cancer 
Control Performance Measures, Project years 2 – 5
Performance Measure Indicator NCCCP Programs that met the indicator*
Partners’ Involvement in CCC
Activities
Year 2 (n=68), n
(%)
Year 3 (n=68), n
(%)
Year 4
(n=69) n, %
Year 5 (n=69)
n, %
All partner meeting convened at
least once during this 12-month
period. (face-to-face)
N/A 54 (79.4) N/A N/A
Each workgroups/subcommittees
met 3-4 times during this 12-month
period (face-to-face or by phone)
N/A 50 (73.5) N/A N/A
Executive committee/steering
committee met 3-4 times during
this 12-month period (face-to-face
or by phone)
N/A 56 (82.4) N/A N/A
Formal by-laws with written roles
and responsibilities are shared
routinely with partners
N/A 48 (70.6) N/A N/A
Partners provide evidence that they
use the CCC Plan
N/A 51 (75.0) N/A N/A
Partners volunteer to take the lead
on action items identified at
meetings
N/A 57 (83.8) N/A N/A
Partners report follow-up on action
taken in a timely manner
N/A 50 (73.5) N/A N/A
CCC program staff members do not lead
the majority of CCC activities
(i.e. partners lead)
N/A 45 (66.2) N/A N/A
Partner organizations implement at
least one strategy focused on the
priorities of the cancer plan†
63 (60.4) N/A N/A N/A
Inclusion of organizations that
represent
underserved/underrepresented
populations in cancer coalitions‡
American Indian/Alaska Native 25/31 (80.7) 25/32 (78.1) N/A N/A
Asian 22/34 (64.7) 21/35 (60.0) N/A N/A
Black or African American 38/44 (86.4) 36/46 (78.3) N/A N/A
Native Hawaiian or Other Pacific 13/16 (81.3) 10/14 (71.4) N/A N/A
Islander
Hispanic or Latino 37/46 (80.4) 36/47 (76.6) N/A N/A
CCC Programs with coalitions that
include at least one organization
representing priority populations
and cultural/ethnic organizations
N/A N/A 35 (50.7) 39 (56.5)
Performance measures that assess
use of cancer surveillance data for
setting priorities and program
planning
Routine Assessment of Cancer Burden Data 60/65 (92.3) 65/67 (97.0) N/A N/A
Years since last assessment, mean
(range)
1.3 (0 – 6) 1.2 (0 – 7) N/A N/A
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Performance Measure Indicator NCCCP Programs that met the indicator*
Partners’ Involvement in CCC
Activities
Year 2 (n=68), n
(%)
Year 3 (n=68), n
(%)
Year 4
(n=69) n, %
Year 5 (n=69)
n, %
Results of midpoint review were
presented to partners during a
partnership meeting
N/A 39/68 (57.4) N/A N/A
A written report of the results from
the midpoint review was provided
to partners
N/A 31/68 (45.6) N/A N/A
The program updated CCC plan
goals or objectives based on a
review of data and trends
28/66 (42.4) 24/58 (41.4) N/A N/A
The program met one or more
action plan objectives for assessing
the burden of cancer
N/A N/A 37 (53.6) 38 (55.1)
Abbreviations: CCC, Comprehensive Cancer Control; N/A, not applicable
*
Data are not available for every indicator throughout the entire time period. Indicators not collected for a given year are denoted with “N/A”. Data 
displayed are for programs who met the indicator (indicated “yes” to the survey question, etc.)
†63 programs provided a response to this question on the proportion of partners implementing cancer plan strategies, with responses ranging from 
12.0 – 100%. The data presented are the mean percentage of partners that programs report. This indicator was originally collected under the domain 
of “implement the cancer plan.”
‡
The denominator is limited to programs who report having a portion of residents in their jurisdiction of a specified racial/ethnic background.
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Table 2
Results of performance measures that assess cancer plan implementation and outcomes of activities, National 
Comprehensive Cancer Control Performance Measures, project years 2 – 5
NCCCP Programs that met the indicator*
Performance measure indicator Year 2(n=68), n
(%)
Year 3
(n=68), n (%)
Year 4 (n=69),
n (%)
Year 5 (n=69),
n (%)
The continuum of cancer care is
addressed in the implementation
priorities with their CCC
coalitions
Primary prevention N/A 63 (92.6) 55 (79.7) 57 (82.6)
Screening/Early detection N/A 67 (98.5) 58 (84.1) 59 (85.5)
Diagnosis N/A 52 (76.5) 24 (34.8) 24 (34.8)
Treatment N/A 53 (77.9) 35 (50.7) 34 (49.3)
Palliation/End-of-Life Care N/A 58 (85.3) 31 (44.9) 33 (47.8)
Survivorship N/A 63 (92.6) 45 (65.2) 48 (69.5)
Evidence-based interventions
are used
Average % of implemented
interventions that are evidence-
based†
53 (60.4) 55 (67.5) 68 (64.0) 69 (63.0)
At least one action plan annual
objective with any evidence-based or
promising practice source
N/A N/A 61 (88.4) 63 (91.3)
At least one action plan annual
objective with practice-
based/program experience – your
own program‡
N/A N/A 35 (50.7) 42 (60.9)
Program evaluation is routinely
conducted
A formal written evaluation plan
has been developed
46/67 (68.7) 48/68 (70.6) 35/69 (50.7) 48/69 (69.6)
Evaluation plan includes these
components:
   Stakeholder involvement 45/45 (100) 46/48 (95.8) N/A N/A
   Data collection and
   analysis methods
43/45 (95.6) 46/48 (95.8) N/A N/A
   How the goals/objectives
   link to outcomes
41/45 (91.1) 45/48 (93.8) N/A N/A
   Potential effects of
   selected activities
31/45 (68.9) 39/48 (81.3) N/A N/A
   Plans for communication
   and utilization of findings
35/45 (77.8) 41/47 (87.2) N/A N/A
   All elements included 28/45 (62.2) 35/48 (72.9) N/A N/A
Progress is demonstrated toward
achieving preset goals for cancer
prevention and control
J Public Health Manag Pract. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Townsend et al. Page 18
NCCCP Programs that met the indicator*
Performance measure indicator Year 2(n=68), n
(%)
Year 3
(n=68), n (%)
Year 4 (n=69),
n (%)
Year 5 (n=69),
n (%)
NCCCP programs routinely
monitor these indicators (years 2-
3) and action plan project period
objectives include these
indicators (years 4-5):§
   Adult smoking 60 (88.2) 52 (76.5) 18 (26.1) 17 (24.6)
   Adolescent smoking 55 (80.9) 44 (64.7) 9 (13.0) 7 (10.1)
   Obesity|| 59 (86.8) 37 (54.4) 5 (7.2) 6 (8.7)
   Breast cancer screening 59 (86.8) 51 (75.0) 16 (23.2) 10 (14.5)
   Cervical cancer
   screening/human
   papillomavirus
   vaccination**
58 (85.3) 47 (69.1) 14 (20.3) 16 (23.2)
   Colorectal cancer
   screening
55 (80.9) 48 (70.6) 29 (42.0) 31 (44.9)
Abbreviations: CCC, Comprehensive Cancer Control; N/A, not applicable
*
Data are not available for every indicator throughout the entire time period. Indicators not collected for a given year are denoted with “N/A”.
†
Data presented are mean % of all interventions that programs report are evidence-based.
‡
These data were included to assess how many programs were using other non evidence-based sources.
§
In year 2, NCCCP programs reported data on each of these six indicators. The percentages presented are the programs who reported data for these 
indicators.
||
Data for years 2 – 3 include adults only. Years 4 – 5 include adolescents and adults.
**
Years 4 – 5 include human papillomavirus vaccination objectives.
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